Burkitt-like Lymphoma
📧 Sign up to get email alerts when something new happens for Burkitt-like Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma [Phase 2]
Phase 2 clinical trial evaluating doxorubicin hydrochloride liposome with rituximab in combination chemotherapy for newly diagnosed Burkitt'…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab with Hyper-CVAD for Burkitt lymphoma and Burkitt-like lymphoma; the study is completed and results were p…
-
CLINICAL_TRIALS withdrawal · 2013-12-10Clinical Trial Update: Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement. [Phase 2]
This Phase 2 trial evaluating Rituximab-HyperCVAD alternating with Rituximab-Methotrexate-Cytarabine for newly diagnosed diffuse large B-cel…
-
CLINICAL_TRIALS research · 2009-09-15Clinical Trial Update: Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults [Phase 4]
Provides an update on a Phase 4 clinical trial evaluating intensified therapy for adults with mature B-cell acute lymphoblastic leukemia, Bu…